ProQR Therapeutics Virtual Investor and Analyst Event on AX-0810 | Nov 03, 2025

ProQR Receives CTA Authorization for AX-0810 and conducted Virtual Investor and Analyst Event on November 3, 2025.

Twitter -   / i101in  

#earningscall #StockMarketNews

If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].